Malaysia merekodkan lebih 120,000 kes denggi setahun. Lebih 200 nyawa terkorban setiap tahun. Selangor + KL menyumbang 40% kes negara.
Anda dah lakukan semua: fogging, abate, kelambu, repellent. Tapi nyamuk Aedes tetap ada — apartment block, lif, surau, sekolah, pejabat. Eksposur adalah kepastian. Soalannya — bila + seteruk mana.
Sehingga 2023, kita hanya ada strategi defensif (kawalan nyamuk + rawatan supportif lepas jangkitan). Sekarang, ada pilihan ofensif: Vaksin Qdenga oleh Takeda — diluluskan KKM untuk umur 6-60 tahun.
Tapi vaksin denggi BUKAN untuk semua. Ada kriteria kelayakan, kontraindikasi, dan considerasi yang ramai tak tahu. Panduan ini menjawab semua persoalan klinikal anda berdasarkan data Pakar Penyakit Berjangkit An-Nur.
Malaysia records over 120,000 dengue cases per year. More than 200 lives lost annually. Selangor + KL contribute 40% of national cases.
You\'ve done everything: fogging, larvicide, mosquito nets, repellent. But Aedes mosquitoes are still around — apartment blocks, lifts, prayer rooms, schools, offices. Exposure is certain. The question is — when + how severe.
Until 2023, we only had defensive strategy (mosquito control + supportive treatment post-infection). Now there\'s an offensive option: Qdenga vaccine by Takeda — approved by MOH for ages 6-60.
But dengue vaccine is NOT for everyone. There are eligibility criteria, contraindications, and considerations many don\'t know. This guide answers all clinical questions based on data from An-Nur Infectious Disease Specialists.
Asas Klinikal — 4 Serotype Virus Denggi
Clinical Basics — 4 Dengue Virus Serotypes
Virus denggi ada 4 serotype berbeza: DENV-1, DENV-2, DENV-3, DENV-4. Setiap satu boleh sebabkan denggi — tapi badan anda kena dapat immunity berasingan untuk setiap satu.
Inilah masalahnya: kalau anda kena DENV-1 dulu, antibodi yang badan keluarkan TAK BOLEH lindungi anda dari DENV-2 sepenuhnya. Malah, antibodi tu mungkin buruk lagi keadaan bila DENV-2 datang — fenomena dipanggil "Antibody-Dependent Enhancement (ADE)".
Inilah sebab jangkitan denggi KEDUA selalunya lebih teruk dari pertama, dengan risiko 7× lebih tinggi untuk severe dengue (haemorrhagic / shock).
The dengue virus has 4 different serotypes: DENV-1, DENV-2, DENV-3, DENV-4. Each can cause dengue — but your body needs separate immunity for each.
Here\'s the problem: if you contract DENV-1 first, the antibodies your body produces CANNOT fully protect you from DENV-2. In fact, those antibodies may make things worse when DENV-2 comes — a phenomenon called "Antibody-Dependent Enhancement (ADE)".
This is why a SECOND dengue infection is typically worse than the first, with 7× higher risk of severe dengue (haemorrhagic / shock).
4 Serotype Denggi — Kenapa Antibodi Lama Tak Cukup
4 Dengue Serotypes — Why Old Antibodies Aren\'t Enough
Setiap serotype = jangkitan berbeza. Antibodi DENV-1 TAK lindungi dari DENV-2.
Each serotype = different infection. DENV-1 antibodies do NOT protect against DENV-2.
DENV-1
DENV-1
Paling lazim di Malaysia 2025
Most common in Malaysia 2025
DENV-2
DENV-2
Sering kaitkan dengan DHF teruk
Often linked to severe DHF
DENV-3
DENV-3
Rising trend tahun 2024-2025
Rising trend 2024-2025
DENV-4
DENV-4
Kurang lazim tapi tetap bahaya
Less common but still dangerous
Vaksin Qdenga — Cara Ia Berfungsi
Qdenga Vaccine — How It Works
Qdenga (TAK-003) adalah vaksin "tetravalent" — bermakna ia melindungi terhadap SEMUA 4 serotype dengan satu pakej. Pelbagai bezanya dengan vaksin lama (Dengvaxia/CYD-TDV):
- Qdenga (baru): Berfungsi untuk yang pernah ATAU tidak pernah kena denggi (seropositive + seronegative). Tiada pre-vaccine blood test diperlukan.
- Dengvaxia (lama): Hanya untuk yang sudah pernah kena denggi. Wajib blood test dulu. Berbahaya untuk seronegative individuals.
Di An-Nur, kami hanya tawarkan Qdenga — vaksin terkini yang lebih selamat dan lebih praktikal untuk populasi Malaysia.
Qdenga (TAK-003) is a "tetravalent" vaccine — meaning it protects against ALL 4 serotypes in one package. Key differences from older vaccine (Dengvaxia/CYD-TDV):
- Qdenga (new): Works for both those who have OR have not had dengue (seropositive + seronegative). No pre-vaccine blood test required.
- Dengvaxia (old): Only for those who\'ve had dengue. Mandatory blood test first. Dangerous for seronegative individuals.
At An-Nur, we only offer Qdenga — the latest vaccine that\'s safer and more practical for the Malaysian population.
Schedule Vaksinasi — 2 Dos, 3 Bulan Jarak
Vaccination Schedule — 2 Doses, 3 Months Apart
Vaksin Qdenga di An-Nur:
- Dos 1: RM248 (per dos)
- Dos 2: 3 bulan kemudian — total RM480 untuk kursus penuh
- Booster: Tiada sehingga 5 tahun (data extension sedang dikaji)
Setelah 2 dos lengkap, immunity terbentuk dalam 1-2 bulan. Efektif 80-90% terhadap severe dengue + hospitalisation.
Qdenga vaccine at An-Nur:
- Dose 1: RM248 (per dose)
- Dose 2: 3 months later — total RM480 for the full course
- Booster: None up to 5 years (extension data being studied)
After both doses, immunity develops in 1-2 months. 80-90% effective against severe dengue + hospitalisation.
Schedule Vaksinasi — 2 Dos Mudah
Vaccination Schedule — 2 Simple Doses
Bayar setiap dos, atau pakej penuh sekaligus untuk save
Pay per dose, or full package upfront to save
Dos 1 — RM248
Dose 1 — RM248
Hari konsultasi awal — pemeriksaan kesihatan + suntikan dos pertama
Initial consultation day — health check + first dose injection
Tunggu 3 Bulan
Wait 3 Months
Sistem imun mula membentuk antibodi. Set reminder untuk follow-up
Immune system starts building antibodies. Set reminder for follow-up
Dos 2 — Total RM480
Dose 2 — Total RM480
Suntikan kedua. Immunity penuh dalam 1-2 bulan kemudian
Second injection. Full immunity in 1-2 months after
Siapa Layak — Siapa TIDAK Boleh?
Who Qualifies — Who CANNOT?
| Kategori Category | ✅ Layak (Eligible) ✅ Eligible | ❌ TIDAK Boleh (Contraindicated) ❌ NOT Eligible |
|---|---|---|
| UmurAge | 6-60 tahun6-60 years | <6 tahun atau >60 tahun<6 years or >60 years |
| Status DenggiDengue Status | Pernah ATAU tidak pernah kenaHas had OR has never had dengue | Sedang kena denggi (tunggu pulih)Currently with dengue (wait until recovered) |
| KehamilanPregnancy | Tidak hamil dan tidak menyusuNot pregnant, not breastfeeding | Hamil atau menyusu (tangguh sehingga selesai)Pregnant or breastfeeding (delay until done) |
| Immune SystemImmune System | NormalNormal | HIV positive, kanser aktif, ubat immunosuppressant (steroid dosis tinggi, chemo)HIV positive, active cancer, immunosuppressant drugs (high-dose steroid, chemo) |
| AlergiAllergies | Tiada alergi vaksinNo vaccine allergy | Anafilaksis pada vaksin lama atau komponenAnaphylaxis to prior vaccine or components |
💡 Perspektif Klinikal — Kos Vaksin vs Kos Hospital
💡 Clinical Perspective — Vaccine Cost vs Hospital Cost
Vaksin RM480 (2 dos lengkap) memang nampak banyak untuk family 4 orang (RM1,920). Tapi bandingkan dengan kos sebenar denggi teruk:
- Hospital warding 5-7 hari: RM3,000-8,000
- ICU jika DHF (Dengue Haemorrhagic Fever): RM15,000-40,000
- Kos cuti kerja: lost income RM2,000-5,000
- Risiko kematian: tak boleh dinilai dalam ringgit
Vaksin RM480 = insurance premium yang sangat berbaloi untuk Malaysian household.
RM480 vaccine (2 complete doses) seems like a lot for a family of 4 (RM1,920). But compare to actual severe dengue cost:
- Hospital ward 5-7 days: RM3,000-8,000
- ICU if DHF (Dengue Haemorrhagic Fever): RM15,000-40,000
- Lost work income: RM2,000-5,000
- Death risk: cannot be valued in ringgit
RM480 vaccine = a very worthwhile insurance premium for the Malaysian household.
RM480 Vaksin vs RM40K Hospital — Math Jujur
RM480 Vaccine vs RM40K Hospital — Honest Math
Yang mana sebenarnya "mahal" untuk Malaysian family?
Which is actually "expensive" for a Malaysian family?
Pilihan: Vaksin Sekarang
Option: Vaccinate Now
RM480 / orang
Family 4 = RM1,920
Protection 4.5+ tahun
80-90% prevent severe
RM480 / person
Family of 4 = RM1,920
4.5+ years protection
80-90% prevent severe
Pilihan: Tunggu & Berdoa
Option: Wait & Pray
RM3-8K hospital ward 5-7 hari
RM15-40K ICU jika DHF
RM2-5K lost income
Risiko kematian
RM3-8K hospital ward 5-7 days
RM15-40K ICU if DHF
RM2-5K lost income
Death risk
Soalan Lazim (FAQ)
FAQ
1. Saya pernah kena denggi. Masih perlu vaksin?
Ya — malah lebih perlu. Antibodi dari jangkitan pertama tak lindungi anda dari serotype lain. Risiko jangkitan kedua 7× lebih teruk. Baca panduan lengkap: Pernah Kena Denggi — Masih Perlu Vaksin?
2. Anak saya umur 8 tahun. Layak ke?
Ya — vaksin Qdenga diluluskan KKM untuk umur 6-60 tahun. Untuk anak, ada considerasi khusus. Baca: Vaksin Denggi untuk Anak — Panduan Ibu Bapa
3. Vaksin halal tak?
Status halal vaksin Qdenga dalam kajian JAKIM. Untuk pesakit Muslim yang risau, JAKIM telah mengeluarkan fatwa darurat untuk vaksin sambil menunggu pengesahan halal rasmi. Pakar An-Nur (hospital Patuh Syariah) dah update dengan latest fatwa.
4. Berapa lama vaksin protect?
Data current menunjukkan immunity lasting sehingga 4.5 tahun selepas 2 dos lengkap. Kajian extension sehingga 8 tahun sedang dijalankan. Booster tidak diperlukan sehingga 5 tahun.
5. Apa side effects vaksin Qdenga?
Side effects biasanya ringan:
- Sakit di tempat suntikan (40%)
- Penat ringan (30%)
- Demam ringan 1-2 hari (15%)
- Sakit otot/sendi (10%)
Side effects serius (anafilaksis) sangat jarang — <1 per 100,000. An-Nur emergency response ready selepas suntikan.
1. I\'ve had dengue before. Do I still need the vaccine?
Yes — even more so. Antibodies from your first infection don\'t protect against other serotypes. Second infection risk is 7× worse. Read the full guide: Already Had Dengue — Still Need Vaccine?
2. My child is 8 years old. Eligible?
Yes — Qdenga is approved by MOH for ages 6-60. There are special considerations for children. Read: Dengue Vaccine for Children — A Parent\'s Guide
3. Is the vaccine halal?
Qdenga\'s halal status is being reviewed by JAKIM. For concerned Muslim patients, JAKIM has issued an emergency fatwa for the vaccine pending official halal certification. An-Nur specialists (Shariah-compliant hospital) are updated with the latest fatwa.
4. How long does the vaccine protect?
Current data shows immunity lasting up to 4.5 years after both doses. Extension studies up to 8 years are ongoing. No booster needed for up to 5 years.
5. What are Qdenga\'s side effects?
Side effects are typically mild:
- Injection site pain (40%)
- Mild fatigue (30%)
- Mild fever 1-2 days (15%)
- Muscle/joint pain (10%)
Serious side effects (anaphylaxis) very rare — <1 per 100,000. An-Nur emergency response ready post-injection.
📚 Sumber Klinikal / Rujukan
📚 Clinical Sources / References
- WHO — Dengue and Severe Dengue Fact Sheet
- WHO — Dengue Vaccine Position Paper
- CDC — Dengue Vaccine Information
- KKM iDengue Portal — Statistik Denggi Malaysia
- NPRA Malaysia — Drug Regulation
- Malaysian Society of Infectious Diseases & Chemotherapy
- Takeda — Qdenga Official Information
- Internal: Pakej Vaksin Denggi An-Nur — RM248/RM480
- Internal: Pernah Kena Denggi — Masih Perlu Vaksin?
- Internal: Vaksin Denggi untuk Anak 6-17 Tahun